1 - 25 of 34 results for author:"Krude H." in Literature citations
Results Customize
› Repeat search in UniProtKB (9)
| Do common variants separate between obese melanocortin-4 receptor gene mutation carriers and non-carriers? The impact of cryptic relatedness. Muhlhaus J., Putter C., Brumm H., Grallert H., Illig T., Scherag S., Reinehr T., Pott W., Albayrak O., Wang H.J. et al. Horm Res Paediatr 77:358-368(2012) · Mapped (1) |
| Testosterone production during puberty in two 46,XY patients with disorders of sex development and novel NR5A1 (SF-1) mutations. Tantawy S., Lin L., Akkurt I., Borck G., Klingmuller D., Hauffa B.P., Krude H., Biebermann H., Achermann J.C., Kohler B. Eur. J. Endocrinol. 167:125-130(2012) · Mapped (6) |
| MC4R dimerization in the paraventricular nucleus and GHSR/MC3R heterodimerization in the arcuate nucleus: is there relevance for body weight regulation? Rediger A., Piechowski C.L., Habegger K., Gruters A., Krude H., Tschop M.H., Kleinau G., Biebermann H. Neuroendocrinology 95:277-288(2012) · Mapped (2) |
| Glucose-dependent insulinotropic polypeptide reduces fat-specific expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 and inhibits release of free fatty acids. Gogebakan O., Andres J., Biedasek K., Mai K., Kuhnen P., Krude H., Isken F., Rudovich N., Osterhoff M.A., Kintscher U. et al. Diabetes 61:292-300(2012) · Mapped (2) |
| New pathogenic thyrotropin receptor mutations decipher differentiated activity switching at a conserved helix 6 motif of family A GPCR. Biebermann H., Winkler F., Handke D., Teichmann A., Gerling B., Cameron F., Eichhorst J., Gruters A., Wiesner B., Kuhnen P. et al. J. Clin. Endocrinol. Metab. 97:E228-32(2012) · Mapped (6) |
| Mutually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors. Rediger A., Piechowski C.L., Yi C.X., Tarnow P., Strotmann R., Gruters A., Krude H., Schoneberg T., Tschop M.H., Kleinau G. et al. J. Biol. Chem. 286:39623-39631(2011) · Mapped (3) |
| Functional characterization of novel loss-of-function mutations in the vasopressin type 2 receptor gene causing nephrogenic diabetes insipidus. Boselt I., Tramma D., Kalamitsou S., Niemeyer T., Nykanen P., Graf K.J., Krude H., Marenzi K.S., Di Candia S., Schoneberg T. et al. Nephrol. Dial. Transplant. 27:1521-1528(2012) · Mapped (1) |
| Monocarboxylate transporter 8 deficiency: altered thyroid morphology and persistent high triiodothyronine/thyroxine ratio after thyroidectomy. Wirth E.K., Sheu S.Y., Chiu-Ugalde J., Sapin R., Klein M.O., Mossbrugger I., Quintanilla-Martinez L., de Angelis M.H., Krude H., Riebel T. et al. Eur. J. Endocrinol. 165:555-561(2011) · Mapped (2) |
| Rescue of melanocortin 4 receptor (MC4R) nonsense mutations by aminoglycoside-mediated read-through. Brumm H., Muhlhaus J., Bolze F., Scherag S., Hinney A., Hebebrand J., Wiegand S., Klingenspor M., Gruters A., Krude H. et al. Obesity (Silver Spring) 20:1074-1081(2012) · Mapped (1) |
| Diabetes caused by insulin gene (INS) deletion: clinical characteristics of homozygous and heterozygous individuals. Raile K., O'Connell M., Galler A., Werther G., Kuhnen P., Krude H., Blankenstein O. Eur. J. Endocrinol. 165:255-260(2011) · Mapped (3) |
| A novel mutation of LHX3 is associated with combined pituitary hormone deficiency including ACTH deficiency, sensorineural hearing loss, and short neck-a case report and review of the literature. Bonfig W., Krude H., Schmidt H. Eur. J. Pediatr. 170:1017-1021(2011) · Mapped (6) |
| Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Procardis Consortium Nat. Genet. 42:937-948(2010) · Mapped (6) |
| Association of variants in gastric inhibitory polypeptide receptor gene with impaired glucose homeostasis in obese children and adolescents from Berlin. Sauber J., Grothe J., Behm M., Scherag A., Grallert H., Illig T., Hinney A., Hebebrand J., Wiegand S., Gruters A. et al. Eur. J. Endocrinol. 163:259-264(2010) · Mapped (3) |
| Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups. Scherag A., Dina C., Hinney A., Vatin V., Scherag S., Vogel C.I., Muller T.D., Grallert H., Wichmann H.E., Balkau B. et al. PLoS Genet. 6:e1000916-e1000916(2010) · Mapped (17) |
| No correlation between androgen receptor CAG and GGN repeat length and the degree of genital virilization in females with 21-hydroxylase deficiency. Welzel M., Schwarz H.P., Hedderich J., Dorr H.G., Binder G., Bramswig J.H., Krude H., Richter-Unruh A., Niedziela M., Gromoll J. et al. J. Clin. Endocrinol. Metab. 95:2443-2450(2010) · Mapped (45) |
| Meta-analysis of the INSIG2 association with obesity including 74,345 individuals: does heterogeneity of estimates relate to study design? Heid I.M., Huth C., Loos R.J., Kronenberg F., Adamkova V., Anand S.S., Ardlie K., Biebermann H., Bjerregaard P., Boeing H. et al. PLoS Genet. 5:e1000694-e1000694(2009) · Mapped (2) |
| Ongoing expression of Nkx2.1 in the postnatal mouse forebrain: potential for understanding NKX2.1 haploinsufficiency in humans? Magno L., Catanzariti V., Nitsch R., Krude H., Naumann T. Brain Res. 1304:164-186(2009) · Mapped (2) |
| Homozygous nonsense and frameshift mutations of the ACTH receptor in children with familial glucocorticoid deficiency (FGD) are not associated with long-term mineralocorticoid deficiency. Chan L.F., Metherell L.A., Krude H., Ball C., O'Riordan S.M., Costigan C., Lynch S.A., Savage M.O., Cavarzere P., Clark A.J. Clin. Endocrinol. (Oxf) 71:171-175(2009) · Mapped (6) |
| Novel mutations in LHX3 are associated with hypopituitarism and sensorineural hearing loss. Rajab A., Kelberman D., de Castro S.C., Biebermann H., Shaikh H., Pearce K., Hall C.M., Shaikh G., Gerrelli D., Grueters A. et al. Hum. Mol. Genet. 17:2150-2159(2008) · Mapped (6) |
| HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. McNay D.E.G., Turton J.P., Kelberman D., Woods K.S., Brauner R., Papadimitriou A., Keller E., Keller A., Haufs N., Krude H. et al. J. Clin. Endocrinol. Metab. 92:691-697(2007) · UniProtKB (1) |
| Arteries define the position of the thyroid gland during its developmental relocalisation. Alt B., Elsalini O.A., Schrumpf P., Haufs N., Lawson N.D., Schwabe G.C., Mundlos S., Gruters A., Krude H., Rohr K.B. Development 133:3797-3804(2006) · Mapped (22) |
| A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Biebermann H., Castaneda T.R., van Landeghem F., von Deimling A., Escher F., Brabant G., Hebebrand J., Hinney A., Tschop M.H., Gruters A. et al. Cell Metab. 3:141-146(2006) · Mapped (6) |
| Mutation analysis of the MCHR1 gene in human obesity. Wermter A.-K., Reichwald K., Buech T., Geller F., Platzer C., Huse K., Hess C., Remschmidt H., Gudermann T., Preibisch G. et al. Eur. J. Endocrinol. 152:851-862(2005) · UniProtKB (1) · Mapped (4) |
| Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Friesema E.C.H., Grueters A., Biebermann H., Krude H., von Moers A., Reeser M., Barrett T.G., Mancilla E.E., Svensson J., Kester M.H.A. et al. |
| Mutationally induced disulfide bond formation within the third extracellular loop causes melanocortin 4 receptor inactivation in patients with obesity. Tarnow P., Schoneberg T., Krude H., Gruters A., Biebermann H. J. Biol. Chem. 278:48666-48673(2003) · Mapped (1) |